More articles from Letter to the Editor

You have access
RESPONSE TO COMMENTS ON HOSKINS ET AL. [(2005) DRUG METAB DISPOS 33:1564–1565]
Harish V. Pai and Vijayalakshmi Ravindranath

Drug Metabolism and Disposition March 2006, 34 (3) 506; DOI: https://doi.org/10.1124/dmd.105.008862
You have access
COMMENTS ON “A MATHEMATICAL DESCRIPTION OF THE FUNCTIONALITY OF CORRECTION FACTORS USED IN ALLOMETRY FOR PREDICTING HUMAN DRUG CLEARANCE”
Iftekhar Mahmood

Drug Metabolism and Disposition March 2006, 34 (3) 507-509; DOI: https://doi.org/10.1124/dmd.105.007187
You have access
RESPONSE TO COMMENTS ON “A MATHEMATICAL DESCRIPTION OF THE FUNCTIONALITY OF CORRECTION FACTORS USED IN ALLOMETRY FOR PREDICTING HUMAN DRUG CLEARANCE”
Huadong Tang and Michael Mayersohn

Drug Metabolism and Disposition March 2006, 34 (3) 510-511; DOI: https://doi.org/10.1124/dmd.105.008359
You have access
COMMENT ON “A FRAMESHIFT MUTATION AND ALTERNATE SPLICING IN HUMAN BRAIN GENERATE A FUNCTIONAL FORM OF THE PSEUDOGENE CYTOCHROME P4502D7 THAT DEMETHYLATES CODEINE TO MORPHINE”
Janelle M. Hoskins, Sharon Marsh and Howard L. McLeod

Drug Metabolism and Disposition October 2005, 33 (10) 1564-1565; DOI: https://doi.org/10.1124/dmd.105.005736
You have access
RESPONSE TO COMMENT ON “A FRAMESHIFT MUTATION AND ALTERNATE SPLICING IN HUMAN BRAIN GENERATE A FUNCTIONAL FORM OF THE PSEUDOGENE CYTOCHROME P4502D7 THAT DEMETHYLATES CODEINE TO MORPHINE”
Harish V. Pai and Vijayalakshmi Ravindranath

Drug Metabolism and Disposition October 2005, 33 (10) 1566; DOI: https://doi.org/10.1124/dmd.105.006155
You have access
RESPONSE TO THE LETTER TO THE EDITOR BY DRS. N. PICARD AND P. MARQUET REGARDING A PUBLICATION: BASU ET AL., DRUG METABOLISM AND DISPOSITION (32:768–773, (2004)
N. K. Basu, L. Kole, S. Kubota and I. S. Owens

Drug Metabolism and Disposition December 2004, 32 (12) 1525; DOI: https://doi.org/10.1124/dmd.104.002345
You have access
PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES
Karen Rowland Yeo, Eleanor M. Howgate, Geoffrey T. Tucker and Amin Rostami-Hodjegan

Drug Metabolism and Disposition December 2004, 32 (12) 1522; DOI: https://doi.org/10.1124/dmd.104.001792
You have access
RESPONSE: PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES
Tommy B. Andersson, Eva Bredberg, Hans Ericsson and Helena SjÖberg

Drug Metabolism and Disposition December 2004, 32 (12) 1523; DOI: https://doi.org/10.1124/dmd.104.002329
You have access
IN VITRO STUDY OF MYCOPHENOLIC ACID GLUCURONIDATION
Nicolas Picard and Pierre Marquet

Drug Metabolism and Disposition December 2004, 32 (12) 1524; DOI: https://doi.org/10.1124/dmd.104.001982
You have access
IS 17α-ETHINYL ESTRADIOL AN INHIBITOR OF CYTOCHROME P450 2C19?
A. David Rodrigues and Ping Lu

Drug Metabolism and Disposition March 2004, 32 (3) 364-365; DOI: https://doi.org/10.1124/dmd.32.3.364

Main menu

User menu

Search

More articles from Letter to the Editor

Pages

Navigate

More Information

ASPET's Other Journals